Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp. in patients admitted with community-acquired pneumonia: A 7-year retrospective evaluation

Journal of Clinical Pathology

Volumn 66, Issue 9, 2013, Pages 797-802

  Engel, M F ^a   Van Manen, L ^a   Hoepelman, A I M ^a   Thijsen, S ^b   Oosterheert, J J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; COMMUNITY ACQUIRED PNEUMONIA; COST; DIAGNOSTIC TEST; ECONOMIC EVALUATION; FEMALE; HUMAN; LEGIONELLA; LEGIONELLA URINARY ANTIGEN TEST; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URINALYSIS;

ANTIBIOTICS; INFECTIONS; LUNG;

ADULT; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HOSPITALS, TEACHING; HUMANS; LEGIONELLA; LEGIONNAIRES' DISEASE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84882851616     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-201209     Document Type: Article

References (22)

1. Wiersinga WJ, Bonten MJ, Boersma WG, et al. SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) Guidelines on the management of community-acquired pneumonia in adults. Neth J Med 2012;2:90-101.
2. Centres for Disease Control and Prevention; National Center for Immunization and Respiratory Diseases. Patient Facts: Learn More about Legionnaires' disease. Jun 2011. http://www.cdc.gov/legionella/patient-facts.htm (accessed 30 Dec 2012).
3. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009;64(Suppl 3):1-55.
4. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):27-72.
5. Schouten JA, Prins JM, Bonten MJ, et al. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia. Neth J Med 2005;8:323-35.
6. Farr BM, Kaiser DL, Harrison BD, et al. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. Thorax 1989;44:1031-5.
7. Sopena N, Sabria-Leal M, Pedro-Botet ML, et al. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest 1998;113:1195-200.
8. Garbino J, Bornand JE, Uckay I, et al. Impact of positive legionella urinary antigen test on patient management and improvement of antibiotic use. J Clin Pathol 2004;57:1302-5.
9. Engel MF, Postma DF, Hulscher ME, et al. Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with communityacquired pneumonia. Eur Respir J 2013 Jan;41(1):123-30.doi: 10.1183/09031936.00029412. Epub 2012 May 31.
10. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;4:388-416.
11. Blazquez RM, Espinosa FJ, Martinez-Toldos CM, et al. Sensitivity of urinary antigen test in relation to clinical severity in a large outbreak of Legionella pneumonia in Spain. Eur J Clin Microbiol Infect Dis 2005;24:488-91.
12. Muder RR, Yu VL. Infection due to Legionella species other than L.pneumophila. Clin Infect Dis 2002;35:990-8.
13. Shimada T, Noguchi Y, Jackson JL, et al. Systematic review and metaanalysis: urinary antigen tests for Legionellosis. Chest 2009;136:1576-85.
14. von Baum H, Ewig S, Marre R, et al. Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis 2008;46:1356-64.
15. Yzerman EP, den Boer JW, Lettinga KD, et al. Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires' disease in The Netherlands. J Clin Microbiol 2002;40:3232-6.
16. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
17. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 2003;58:377-82.
18. Wiersinga WJ, Bonten MJ, Boersma WG, et al. SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. Neth J Med 2012;70(2): 90-101.
19. Dionne M, Hatchette T, Forward K. Clinical utility of a Legionella pneumophila urinary antigen test in a large university teaching hospital. Can J Infect Dis 2003;2:85-8.
20. Falguera M, Ruiz-Gonzalez A, Schoenenberger JA, et al. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Thorax 2010;65:101-6.
21. Lettinga KD, Verbon A, Weverling GJ, et al. Legionnaires' disease at a Dutch flower show: prognostic factors and impact of therapy. Emerg Infect Dis 2002;8:1448-54.
22. Endeman H, Schelfhout V, Voorn GP, et al. Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scand J Infect Dis 2008;40:715-20.